Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 21391232)

1.

CR1 is associated with amyloid plaque burden and age-related cognitive decline.

Chibnik LB, Shulman JM, Leurgans SE, Schneider JA, Wilson RS, Tran D, Aubin C, Buchman AS, Heward CB, Myers AJ, Hardy JA, Huentelman MJ, Corneveaux JJ, Reiman EM, Evans DA, Bennett DA, De Jager PL.

Ann Neurol. 2011 Mar;69(3):560-9. doi: 10.1002/ana.22277. Epub 2011 Mar 9.

2.

Complement receptor 1 (CR1) and Alzheimer's disease.

Crehan H, Holton P, Wray S, Pocock J, Guerreiro R, Hardy J.

Immunobiology. 2012 Feb;217(2):244-50. doi: 10.1016/j.imbio.2011.07.017. Epub 2011 Jul 23. Review.

PMID:
21840620
3.

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. Review.

PMID:
22710919
4.

Genome-wide association studies: is there a genotype for cognitive decline in older persons with type 2 diabetes?

Abbatecola AM, Olivieri F, Corsonello A, Antonicelli R, Corica F, Lattanzio F.

Curr Pharm Des. 2011;17(4):347-56. Review.

PMID:
21352095
5.

Beta-amyloid deposition and the aging brain.

Rodrigue KM, Kennedy KM, Park DC.

Neuropsychol Rev. 2009 Dec;19(4):436-50. doi: 10.1007/s11065-009-9118-x. Epub 2009 Nov 12. Review.

6.

Relationship between genetic risk factors and markers for Alzheimer's disease pathology.

Elias-Sonnenschein LS, Bertram L, Visser PJ.

Biomark Med. 2012 Aug;6(4):477-95. doi: 10.2217/bmm.12.56. Review.

PMID:
22917148
7.

Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.

Davis PR, Head E.

Front Pharmacol. 2014 Mar 21;5:47. doi: 10.3389/fphar.2014.00047. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk